Literature DB >> 875316

[Radioimmunological estimation of digoxin in urine (author's transl)].

K Maertin, N Rietbrock.   

Abstract

When separating free and antibody bound digoxin, dextrancoated charcoal suspensions in protein-free urine dilutions develop an improve sieve effect which improves with aging of the suspensions. On addition of albumin to the dilution medium (buffer), the adsorptive capacities become stabilized. In urine dilutions less than of 1:50, false positive digoxin concentrations were measured. Determinations of 0-5 ng digoxin/ml in the diluted urine (1:100) and in the buffer solution show identical results. The recovery of added digoxin (1 ng and 2 ng/ml) is 100%; the lower detection limit is 3.6 mug/l urine. Between-assay variation for means of duplicates shows in the main measuring range (1.5-2.8 ng digoxin/ml) a variation coefficient less than of 4.5%; for a commercial test this value is distinctly higher. Dihydrodigoxin is measured at 3% only. Application of this method for measuring cumulative glycoside elimination of 5 healthy persons (0.5 mg digoxin daily intravenously during 2 weeks) results in a minimal interindividual variation of 5.1%. In a test preparation with a bioavailability of 94.6% the variation is 5.2%.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 875316     DOI: 10.1007/bf01488580

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  34 in total

1.  Standardization of incubation time and temperature for eight radioimmunoassays.

Authors:  P H Lenz; G H Wien; J M Toth
Journal:  Clin Chem       Date:  1975-07       Impact factor: 8.327

2.  [Therapeutic equivalence and inequivalence of chemically identical substances using cardiac glycosides for an example (author's transpl)].

Authors:  N Rietbrock
Journal:  Arzneimittelforschung       Date:  1976

Review 3.  Principles of competitive binding assays (saturation analysis). 1. Equilibrium techniques.

Authors:  A Zettner
Journal:  Clin Chem       Date:  1973-07       Impact factor: 8.327

4.  Variability of standard curves in radioimmunoassay of plasma digoxin.

Authors:  G H Burnett; R L Conklin; G W Wasson; A A MacKinney
Journal:  Clin Chem       Date:  1973-07       Impact factor: 8.327

5.  [Studies on the pharmacokinetics of digoxin].

Authors:  H J Gilfrich; G Bodem; C A Chidsey
Journal:  Arzneimittelforschung       Date:  1973-11

6.  The radioimmunoassay of plasma-digoxin.

Authors:  J J Zeegers; A H Maas; A F Willebrands; H H Kruyswijk; G Jambroes
Journal:  Clin Chim Acta       Date:  1973-02-28       Impact factor: 3.786

7.  Variation in biologic availability of digoxin from four preparations.

Authors:  J Lindenbaum; M H Mellow; M O Blackstone; V P Butler
Journal:  N Engl J Med       Date:  1971-12-09       Impact factor: 91.245

8.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

9.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

10.  Digoxin radioimmunoassay: sephadex separation of free from antibody-bound digoxin.

Authors:  N J Bundgaard Christiansen; M Damkjaer Nielsen
Journal:  Clin Chim Acta       Date:  1972-11       Impact factor: 3.786

View more
  2 in total

1.  [Isomerisation and bioavailability of beta- and alpha-acetyldigoxin (author's transl)].

Authors:  N Rietbrock; H F Vöhringer; J Kuhlmann; K Maertin
Journal:  Klin Wochenschr       Date:  1977-07-01

2.  Overall pharmacokinetics during prolonged treatment of healthy volunteers with digoxin and beta-methyldigoxin.

Authors:  F Keller; H P Blumenthal; K Maertin; N Rietbrock
Journal:  Eur J Clin Pharmacol       Date:  1977-12-16       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.